IL79965A - Pharmaceutical composition comprising an angiotensin converting enzyme inhibitor for the treatment of high blood pressure - Google Patents

Pharmaceutical composition comprising an angiotensin converting enzyme inhibitor for the treatment of high blood pressure

Info

Publication number
IL79965A
IL79965A IL79965A IL7996586A IL79965A IL 79965 A IL79965 A IL 79965A IL 79965 A IL79965 A IL 79965A IL 7996586 A IL7996586 A IL 7996586A IL 79965 A IL79965 A IL 79965A
Authority
IL
Israel
Prior art keywords
treatment
converting enzyme
enzyme inhibitor
pharmaceutical composition
angiotensin converting
Prior art date
Application number
IL79965A
Other versions
IL79965A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6280420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL79965(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL79965A0 publication Critical patent/IL79965A0/en
Publication of IL79965A publication Critical patent/IL79965A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Toys (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The preparation contains an angiotensin converting enzyme inhibitor and a loop diuretic.
IL79965A 1985-09-09 1986-09-08 Pharmaceutical composition comprising an angiotensin converting enzyme inhibitor for the treatment of high blood pressure IL79965A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853532036 DE3532036A1 (en) 1985-09-09 1985-09-09 PHARMACEUTICAL PREPARATION FOR TREATING HIGH PRESSURE

Publications (2)

Publication Number Publication Date
IL79965A0 IL79965A0 (en) 1986-12-31
IL79965A true IL79965A (en) 1990-08-31

Family

ID=6280420

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79965A IL79965A (en) 1985-09-09 1986-09-08 Pharmaceutical composition comprising an angiotensin converting enzyme inhibitor for the treatment of high blood pressure

Country Status (19)

Country Link
EP (1) EP0215357B1 (en)
JP (1) JPH089549B2 (en)
KR (1) KR940010032B1 (en)
AT (1) ATE75610T1 (en)
AU (1) AU597270B2 (en)
CA (1) CA1340722C (en)
DE (2) DE3532036A1 (en)
DK (1) DK166755B1 (en)
ES (1) ES2001940A6 (en)
FI (1) FI863594L (en)
GR (1) GR862285B (en)
HU (1) HU200685B (en)
IE (1) IE59308B1 (en)
IL (1) IL79965A (en)
NO (1) NO863583L (en)
NZ (1) NZ217489A (en)
PH (1) PH23716A (en)
PT (1) PT83322B (en)
ZA (1) ZA866810B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
DK9200258U4 (en) * 1992-03-11 1993-07-23 Merck & Co Inc Pharmaceutical preparation containing enalapril for use in hypertension
WO2001080895A2 (en) * 2000-04-26 2001-11-01 First Horizon Pharmaceutical Corporation Methods and compositions for the treatment of cardiac indications
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
PL3173075T3 (en) 2015-11-27 2019-04-30 Accupharma Spolka Z Ograniczona Odpowiedzialnoscia Pharmaceutical combination preparation of ace inhibitor and loop diuretic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283407A (en) * 1977-09-28 1981-08-11 Science Union Et Cie Thiopropionamides, and the pharmaceutical compositions
US4217347A (en) * 1977-12-27 1980-08-12 E. R. Squibb & Sons, Inc. Method of treating hypertension and medicaments therefor
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2419728A1 (en) * 1979-01-05 1979-10-12 Science Union & Cie Antihypertensive compsns. - of an angiotensin-I to II enzyme, inhibitor, a diuretic and/or a peripheral vasodilator
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
JPS56145220A (en) * 1980-04-10 1981-11-11 Dainippon Pharmaceut Co Ltd Antihypertensive agent containing prolylamino acid derivative and diuretic agent as main constituent

Also Published As

Publication number Publication date
EP0215357A2 (en) 1987-03-25
JPH089549B2 (en) 1996-01-31
ZA866810B (en) 1987-04-29
GR862285B (en) 1987-01-12
DK427886D0 (en) 1986-09-08
DE3532036A1 (en) 1987-03-26
HUT41640A (en) 1987-05-28
DK166755B1 (en) 1993-07-12
NO863583L (en) 1987-03-10
CA1340722C (en) 1999-09-07
FI863594A7 (en) 1987-03-10
IL79965A0 (en) 1986-12-31
NO863583D0 (en) 1986-09-08
HU200685B (en) 1990-08-28
DK427886A (en) 1987-03-10
IE59308B1 (en) 1994-02-09
AU6243186A (en) 1987-03-12
KR870002844A (en) 1987-04-13
PT83322B (en) 1989-05-12
PT83322A (en) 1986-10-01
PH23716A (en) 1989-09-27
ATE75610T1 (en) 1992-05-15
AU597270B2 (en) 1990-05-31
NZ217489A (en) 1990-07-26
ES2001940A6 (en) 1988-07-01
FI863594L (en) 1987-03-10
DE3685177T (en) 1992-06-11
EP0215357B1 (en) 1992-05-06
KR940010032B1 (en) 1994-10-21
FI863594A0 (en) 1986-09-05
JPS6261928A (en) 1987-03-18
EP0215357A3 (en) 1989-07-26
DE3685177D1 (en) 1992-06-11
IE862392L (en) 1987-03-09

Similar Documents

Publication Publication Date Title
GR890100838A (en) A novel therapeutic active compound and preparation method therefore.
ZA896468B (en) Lyophilization of red blood cells
AU5804686A (en) Regulation of degradation processes in bone
AU1924588A (en) Non-bunching cinch ring for self-applied blood pressure cuff
AU577929B2 (en) Surgical suction safety valve
IL79965A0 (en) Pharmaceutical composition comprising an angiotensin converting enzyme inhibitor for the treatment of high blood pressure
AU7071487A (en) Chlorpheniramine therapy
AU7186487A (en) Use of D. bardawil as a source of vitamin A and a yolk-color enhancing agent
AR243513A1 (en) Procedure for the preparation of 1-phenylquinazoline-1h,3h-2,4-diones and 1-phenylpyride 2,3-d pyrimidine-1h,3h-2,4-diones.
AU7999687A (en) Active compounds for preventing tumor metastases
EP0215395A3 (en) Pharmaceutical composition for retarding and reducing cachexia
NO863113D0 (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLOCARBONYL AND ACETYL-THIAZOLONES.
NZ219920A (en) Purification of t.p.a. (tissue plasminogen activator)
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
IE872614L (en) Pharmaceutical composition for the treatment of high blood¹pressure
AU613510B2 (en) Use of zofenopril for the treatment of rheumatoid arthritis
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases
FI851969A7 (en) Tetrahydronaphthalenols suitable for the treatment of high blood pressure.
GB8709444D0 (en) Reduction of high blood pressure
AU7125887A (en) Peptides affecting blood pressure regulation
AR242544A1 (en) A procedure for the preparation of an extremely pure active alumina, and the alumina thus obtained.
JO1498B1 (en) New Medicine for Joints& Nerves
CS719388A1 (en) Derivatives of thioallophanic acid
AR243536A1 (en) A procedure for the preparation of n-alkylated dipeptides and their esters.
JO1238B1 (en) pharmaceutical formulations comprising human insulin ,human c-peptide ,and human proinsuline

Legal Events

Date Code Title Description
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
EXP Patent expired